Vivos Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Vivos Therapeutics, Inc. (VVOS) reported Increase (Decrease) in Contract with Customer, Liability of $104.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-14
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $88.00K.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $16.00K.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$59.00K.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $53.00K.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$514.00K.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$1.43M.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$611.00K, a 195.77% decline from fiscal 2022.
- Vivos Therapeutics, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was $638.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $104.00K 10-Q · filed 2026-08-14 | $45.00K derived: sum of 3 quarters · filed 2026-08-14 | $98.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $16.00K 10-Q · filed 2026-05-20 | -$43.00K derived: sum of 2 quarters · filed 2026-05-20 | $10.00K derived: sum of 3 quarters · filed 2026-05-20 | -$99.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$6.00K derived: sum of 2 quarters · filed 2026-04-15 | -$115.00K derived: sum of 3 quarters · filed 2026-08-14 | -$514.00K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$56.00K derived: sum of 2 quarters · filed 2026-08-14 | -$455.00K 10-Q · filed 2025-11-19 | -$954.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$508.00K 10-Q · filed 2026-08-14 | -$1.01M derived: sum of 3 quarters · filed 2026-08-14 | -$1.66M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$399.00K 10-Q · filed 2026-05-20 | -$898.00K derived: sum of 2 quarters · filed 2026-05-20 | -$1.55M derived: sum of 3 quarters · filed 2026-05-20 | -$2.34M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | -$499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$1.15M derived: sum of 2 quarters · filed 2026-04-15 | -$1.94M derived: sum of 3 quarters · filed 2026-04-15 | -$1.43M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$655.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$1.44M derived: sum of 2 quarters · filed 2025-11-19 | -$935.00K 10-Q · filed 2025-11-19 | -$1.12M derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | -$784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$280.00K 10-Q · filed 2025-08-19 | -$467.00K derived: sum of 3 quarters · filed 2025-08-19 | -$476.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | $504.00K 10-Q · filed 2025-05-15 | $317.00K derived: sum of 2 quarters · filed 2025-05-15 | $308.00K derived: sum of 3 quarters · filed 2025-05-15 | $33.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$196.00K derived: sum of 2 quarters · filed 2025-03-31 | -$471.00K derived: sum of 3 quarters · filed 2025-03-31 | -$611.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$284.00K derived: sum of 2 quarters · filed 2024-11-14 | -$424.00K 10-Q · filed 2024-11-14 | $32.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$415.00K 10-Q · filed 2024-08-14 | $41.00K derived: sum of 3 quarters · filed 2024-08-14 | $225.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$140.00K 10-Q · filed 2024-05-14 | $316.00K derived: sum of 2 quarters · filed 2024-07-30 | $500.00K derived: sum of 3 quarters · filed 2024-07-30 | $738.00K derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | $456.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | $640.00K derived: sum of 2 quarters · filed 2024-07-30 | $878.00K derived: sum of 3 quarters · filed 2024-07-30 | $638.00K 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $422.00K derived: sum of 2 quarters · filed 2023-11-14 | $182.00K 10-Q · filed 2023-11-14 | -$1.11M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$2.00K 10-Q · filed 2023-08-16 | -$1.30M derived: sum of 3 quarters · filed 2023-08-16 | -$1.72M derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | -$240.00K 10-Q · filed 2023-06-08 | -$56.00K 10-Q · filed 2022-05-16 | -$1.54M derived: sum of 2 quarters · filed 2023-06-08 | -$1.96M derived: sum of 3 quarters · filed 2023-06-08 | -$643.00K derived: sum of 4 quarters · filed 2023-06-08 | |||
| 2021-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.72M derived: sum of 2 quarters · filed 2023-03-30 | -$403.00K derived: sum of 3 quarters · filed 2023-03-30 | -$539.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $894.00K derived: sum of 2 quarters · filed 2022-12-20 | $758.00K 10-Q · filed 2022-12-20 | $758.48K 10-Q · filed 2021-11-15 | $551.86K derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-06-30 | $1.31M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $1.18M 10-Q · filed 2022-12-20 | $1.18M 10-Q · filed 2021-08-12 | $970.86K derived: sum of 3 quarters · filed 2022-12-20 | $1.07M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-03-31 | -$136.00K 10-Q/A · filed 2022-11-25 | -$135.64K 10-Q · filed 2021-05-17 | -$342.14K derived: sum of 2 quarters · filed 2022-11-25 | -$243.35K derived: sum of 3 quarters · filed 2022-11-25 | $177.04K derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | -$206.15K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$107.36K derived: sum of 2 quarters · filed 2022-03-31 | $313.04K derived: sum of 3 quarters · filed 2022-03-31 | -$10.00K 10-K · filed 2022-03-31 | -$9.57K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $98.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $519.18K derived: sum of 2 quarters · filed 2021-11-15 | $196.15K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $420.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $97.36K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$323.04K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | $2.06M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |